Health Minister Mandaviya to review COVID situation on Dec. 21 amid spurt in cases in U.S., China

The Minister will review the COVID-19 situation at 11 am on Wednesday considering the international scenario, they said.

Published - December 20, 2022 08:22 pm IST - New Delhi

Union Health Minister Mansukh Mandaviya speaks in the Rajya Sabha during the ongoing Winter Session of Parliament, in New Delhi, on December 20, 2022

Union Health Minister Mansukh Mandaviya speaks in the Rajya Sabha during the ongoing Winter Session of Parliament, in New Delhi, on December 20, 2022 | Photo Credit: PTI

Amid a fresh spurt in COVID-19 cases in Japan, South Korea, Brazil, China and the U.S., Union Health Minister Mansukh Mandaviya will review the pandemic situation on December 21, 2022, official sources said.

The Minister will review the COVID-19 situation at 11 am on Wednesday considering the international scenario, they said.

Earlier on Tuesday, the Health Ministry urged all states and Union territories to ramp up the whole genome sequencing of positive samples to keep track of newer variants.

In a letter to States and Union Territories, Union Health Secretary Rajesh Bhushan said such an exercise will enable timely detection of newer variants, if any, circulating in the country and will facilitate undertaking of requisite public health measures.

He highlighted that India with its focus on the five-fold strategy of test-track-treat-vaccination and adherence to Covid-appropriate behaviour has been able to restrict the transmission of the coronavirus and is having around 1,200 cases on a weekly basis.

Public health challenge of COVID-19 still persists around the world with around 35 lakh cases being reported weekly, Mr. Bhushan said.

"In view of the sudden spurt of cases being witnessed in Japan, United States of America, Republic of Korea, Brazil and China, it is essential to gear up the whole genome sequencing of positive case samples to track the variants through Indian SARS-CoV-2 Genomics Consortium (INSACOG) network," he said.

"In this context, all states are requested to ensure that as far as possible samples of all positive cases, on a daily basis, are sent to the designated INSACOG Genome Laboratories that are mapped to states and UTs," he added.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.